Giovanni Caforio, President, US Pharmaceuticals at BRISTOL MYERS SQUIBB CO (BMY), sold 20,350 shares at $36.19 ($736K) on 2013-01-28, disclosed to the SEC on 2013-01-28.
Open-market sale of $736k BMY by President, US Pharmaceuticals. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| BMY | SELL | 2022-09-16 | $3.6M | — | Filing → |
| BMY | SELL | 2022-06-14 | $2.2M | — | Filing → |
| BMY | SELL | 2022-03-23 | $1.8M | — | Filing → |